Skip to main content
Jordan Graff, MD, Ophthalmology, Phoenix, AZ

JordanMackayGraffMDFACS

Ophthalmology • Phoenix, AZ

Retinal Disease

Parter, BDP Eye Center Clinical Assist. Professor Ophthalmology UA Phx

Join to view full profile

Dr. Graff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Graff's full profile

Already have an account?

  • Office

    4800 N 22nd St
    Ste 120
    Phoenix, AZ 85016
    Phone+1 602-955-1000
    Fax+1 602-508-4830

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsFellowship, Surgical Retina and Vitreous, 2007 - 2009
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 2004 - 2007
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 2003 - 2004
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2003

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2009 - 2025
  • IA State Medical License
    IA State Medical License 2003 - 2011
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
  • Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • FDA Approves Susvimo for Diabetic Macular Edema
    FDA Approves Susvimo for Diabetic Macular EdemaFebruary 6th, 2025
  • FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
    FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related BlindnessFebruary 4th, 2025
  • Mehrdad Ghoreishi, MD, a Cardiothoracic Surgeon with University of Maryland Medical Center
    Mehrdad Ghoreishi, MD, a Cardiothoracic Surgeon with University of Maryland Medical CenterJune 15th, 2022
  • Join now to see all

Professional Memberships

Dr. Jordan Graff, Dr. Jordan Graff, MD, Dr. J Graff, Dr. Jordan Mackay Graff